27 February 2026
27 February 2026
The agreement includes Ipsen’s investment in additional equipment at Quotient Sciences’ facility in Boothwyn, Pennsylvania, US.
The trial involved 14 participants, with multiple operators conducting several measurements on each of them.
The randomised, open-label, 52-week trial enrolled 1,698 patients.
Quantum Surgical has developed the Epione robotic platform for early-stage tumour interventions.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
